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Abstract
Background: Transcranial Direct Current Stimulation (tDCS) is an emerging approach for improving capacity in
activities of daily living (ADL) and upper limb function after stroke. However, it remains unclear what type of tDCS
stimulation is most effective. Our aim was to give an overview of the evidence network regarding the efficacy and
safety of tDCS and to estimate the effectiveness of the different stimulation types.
Methods: We performed a systematic review of randomised trials using network meta-analysis (NMA), searching
the following databases until 5 July 2016: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE,
EMBASE, CINAHL, AMED, Web of Science, and four other databases. We included studies with adult people with
stroke. We compared any kind of active tDCS (anodal, cathodal, or dual, that is applying anodal and cathodal tDCS
concurrently) regarding improvement of our primary outcome of ADL capacity, versus control, after stroke.
PROSPERO ID: CRD42016042055.
Results: We included 26 studies with 754 participants. Our NMA showed evidence of an effect of cathodal tDCS in
improving our primary outcome, that of ADL capacity (standardized mean difference, SMD = 0.42; 95% CI 0.14 to 0.
70). tDCS did not improve our secondary outcome, that of arm function, measured by the Fugl-Meyer upper
extremity assessment (FM-UE). There was no difference in safety between tDCS and its control interventions,
measured by the number of dropouts and adverse events.
Conclusion: Comparing different forms of tDCS shows that cathodal tDCS is the most promising treatment option
to improve ADL capacity in people with stroke.
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Background
An emerging approach for enhancing neural plasticity
and hence rehabilitation outcomes after stroke is non-
invasive brain stimulation (NIBS). Several stimulation
procedures are available, such as repetitive transcranial
magnetic stimulation (rTMS) [1], transcranial direct
current stimulation (tDCS) [2–4], transcranial alternat-
ing current stimulation (tACS) [5], and transcranial
pulsed ultrasound (TPU) [6]. In recent years a consider-
able evidence base for NIBS has emerged, especially for
rTMS and tDCS.
tDCS is relatively inexpensive, easy to administer and
portable, hence constituting an ideal adjuvant therapy
during stroke rehabilitation. It works by applying a weak
and constant direct current to the brain and has the
ability to either enhance or suppress cortical excitability,
with effect lasting up to several hours after the
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stimulation [7–9]. Hypothetically, this technique makes
tDCS a potentially useful tool to modulate neuronal in-
hibitory and excitatory networks of the affected and the
non-affected hemisphere post stroke to enhance, for ex-
ample, upper limb motor recovery [10, 11]. Three differ-
ent stimulation types can be distinguished.
 In anodal stimulation, the anodal electrode (+)
usually is placed over the lesioned brain area and the
reference electrode over the contralateral orbit [12].
This leads to subthreshold depolarization, hence
promoting neural excitation [3].
 In cathodal stimulation, the cathode (−) usually is
placed over the non-lesioned brain area and the ref-
erence electrode over the contralateral orbit [12],
leading to subthreshold polarization and hence inhi-
biting neural activity [3].
 Dual tDCS means the simultaneous application of
anodal and cathodal stimulation [13].
However, the literature does not provide clear guide-
lines, not only regarding the tDCS type, but also regard-
ing the electrode configuration [14], the amount of
current applied and the duration of tDCS, or the ques-
tion if tDCS should be applied as a standalone therapy
or in combination with other treatments, like robot-
assisted therapy [15].
Rationale
There is so far conflicting evidence from systematic re-
views of randomised controlled trials on the effective-
ness of different tDCS approaches after stroke. For
example, over the past two decades more than 30 rando-
mised clinical trials have investigated the effects of dif-
ferent tDCS stimulation techniques for stroke, and there
are 55 ongoing trials [16]. However, the resulting net-
work of evidence from randomised controlled trials
(RCTs) investigating different types of tDCS (i.e., anodal,
cathodal or dual) as well as their comparators like sham
tDCS, physical rehabilitation or pharmacological agents
has not yet been analyzed in a systematic review so far.
A network meta-analysis (NMA), also known as mul-
tiple treatment comparison meta-analysis or mixed
treatment comparison analysis, allows for a quantitative
synthesis of the evidence network. This is made possible
by combining direct evidence from head-to-head com-
parisons of three or more interventions within rando-
mised trials with indirect evidence across randomised
trials on the basis of a common comparator [17–20].
Network meta-analysis has many advantages over trad-
itional pairwise meta-analysis, such as visualizing and fa-
cilitating the interpretation of the wider picture of the
evidence and improving understanding of the relative
merits of these different types of neuromodulation when
compared to sham tDCS and/or another comparator
such as exercise therapy and/or pharmacological agents
[21, 22]. By borrowing strength from indirect evidence
to gain certainty about all treatment comparisons, net-
work meta-analysis allows comparative effects that have
not been investigated directly in randomised clinical tri-
als to be estimated and ranked [22, 23].
Objective
The aim of our systematic review with NMA was to give
an overview of the evidence network of randomised con-
trolled trials of tDCS (anodal, cathodal, or dual) for im-
proving capacity in activities of daily living (ADL) and
upper limb function after stroke, as well as its safety,
and to estimate and rank the relative effectiveness of the
different stimulation types, while taking into account po-
tentially important treatment effect modifiers.
Methods
Protocol and registration
We published a study protocol, which has been regis-
tered in the PROSPERO database under the ID
CRD42016042055. Our protocol adheres to the PRISMA
extension statement for NMA [24].
Role of the funding source
There was no funding source for this study.
Eligibility criteria
We included studies with adults who had experienced a
stroke. We compared any kind of active tDCS (anodal,
cathodal, or dual, that is applying anodal and cathodal
tDCS concurrently) for improving our primary outcome
of ADL capacity and our secondary outcome of arm
function after stroke. Another secondary outcome was
safety, measured by the number of dropouts and adverse
events. We defined active tDCS as any application of
direct current to the skull lasting longer than 1 min.
This is approximately the time it takes to fade in and
fade out the sham application of tDCS in order to pro-
duce perceivable sensations on the skin similar to active
tDCS [25]. We included all studies with outcome mea-
sures evaluating ADL capacity, and for arm motor func-
tion we included all studies using the Fugl-Meyer upper
extremity assessment (UE-FM). We included all genuine
RCTs and genuine randomised controlled cross-over tri-
als which compared tDCS with any other intervention.
We analyzed only the first intervention phase of trials
with a cross-over design, and assumed between-group
differences to be identical to those in trials with a paral-
lel group design. We combined different stimulation du-
rations, different electrical currents applied and different
stimulation locations for the same stimulation type (that
is anodal, cathodal, or dual tDCS).
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Information sources
We searched the following databases until 5 July 2016:
Cochrane Central Register of Controlled Trials (CEN-
TRAL; the Cochrane Library; 2016, Issue 7), MEDLINE
(from 1948), EMBASE (from 1980), CINAHL (from
1982), AMED (from 1985), Web of Science (from 1899),
Physiotherapy Evidence Database, Rehabdata, COM-
PENDEX (from 1969) and INSPEC (from 1969). There
were no language restrictions. In order to identify fur-
ther published and unpublished trials, we searched trial
registers and reference lists, hand-searched conference
proceedings and contacted authors and equipment
manufacturers.
Search
The search strategy for MEDLINE can be found in Add-
itional file 1. This search strategy was adapted for the
other databases.
Study selection
One review author (BE) excluded obviously irrelevant
studies by reading titles and abstracts. We retrieved the
full text of the remaining studies, which were then
ranked by two review authors (JK, BE) as relevant, pos-
sibly relevant, or irrelevant according to our inclusion
criteria. Two review authors (JK, JM) decided whether
the possibly relevant publications fitted the PICOS strat-
egy (Patient, Intervention, Comparison, Outcome, Study
type) of our research question. We excluded all trials
ranked as irrelevant and tested all trials ranked as rele-
vant or possibly relevant for inclusion. Disagreements
were resolved by discussions with all review authors.
Data collection process
Two review authors (BE, JM) independently extracted
trial and summary outcome data from the trials.
Data items
We used checklists to independently assess the following
items: (1) methods of random sequence generation, (2)
methods of allocation concealment, (3) blinding of out-
come assessors, participants and personnel, (4) use of an
intention-to-treat analysis, (5) adverse effects and drop-
outs, (6) important differences in prognostic factors, (7)
participants (number, age, time from stroke onset to
study entry), (8) comparison (details of interventions in
treatment and control groups, duration of treatment and
details of co-interventions in the groups) and (9) out-
comes at the end of the study.
Geometry of the network
The geometry of the network characterizes the relation
and precision of direct comparisons. At the level of type
of intervention we analyzed what type of tDCS (anodal,
cathodal, or dual) was compared with a particular con-
trol intervention. The geometry of the network was
assessed by generating network graphs [26]. Each type of
intervention represents a node in the network. Rando-
mised comparisons between interventions are shown as
links between the nodes. Multi-arm studies are indicated
by colored polygons [27].
Risk of bias within individual studies
We assessed risk of bias of included studies by the
Cochrane risk of bias tool at study and at outcome level
[28]. The results were incorporated into our sensitivity
analysis, where only studies with low risk of bias were
included. We presented the results for each outcome in
a separate figure.
Summary measures
Considering studies that used the same outcome meas-
ure for an outcome, we calculated Mean Differences
(MD) and their corresponding 95% Confidence Intervals
(CI). Including studies that did not use the same out-
come measure, but did measure the same underlying
construct, we calculated Standardized Mean Differences
(SMD) and their corresponding 95% CIs. We expected
the number of dropouts and adverse events to be rare
and therefore calculated the Risk Difference (RD) and
corresponding 95% CIs as the summary measure. For all
comparisons we generated contrast-based forest plots.
We performed a relative ranking of the competing inter-
ventions according to their P-scores [27]. The P-score of
an intervention, which may range from 0 to 1 and, can
be interpreted as the mean certainty of its superiority
and thus is comparable to its surface under the cumula-
tive ranking curve (SUCRA) [26, 29]. All statistical ana-
lyses have been performed with the statistical software R
version 3.2.2 [30], package “netmeta” version 0.8–0 [27].
Planned method of analysis
This network meta-analysis was based on a frequentist
weighted least squares approach [31, 32], which is
roughly equivalent to maximum likelihood estimation
[29]. This approach follows the graph-theoretical meth-
odology and allows incorporation of multi-arm trials
[32]. The analysis is based on two assumptions: (a) inde-
pendence of studies and (b) consistency of the under-
lying effects (transitivity assumption) [29]. We
considered the treatment effects to differ between the
proof-of-concept trials, and therefore applied a random-
effects model to estimate summary treatment effects,
based on treatment contrasts.
Assessment of inconsistency
As proposed by Higgins et al. for network meta-
analyses, we used a generalized Cochran’s Q statistic for
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multivariate meta-analysis to test the homogeneity and
inconsistency assumptions [33, 34]. This Q statistic con-
tains one within-design Q statistic and one between-
design Q statistic, the latter being calculated on the basis
of a full design-by-treatment interaction random-effects
model, thus embracing the concept of design inconsist-
ency [34]. We assessed inconsistency locally (that is be-
tween pairwise comparisons) using the net heat plot
[34]. The net heat plot is based on a global chi-squared
test for inconsistency based on the comparison of an in-
consistency model and a consistency model [34]. It iden-
tifies inconsistency between specific direct evidence in
the network and provides possible drivers [34].
Risk of bias across studies
We assessed the risk of bias regarding selective reporting
by comparing the published protocol of a study with the
corresponding full text obtained by our electronic
search.
Additional analyses
We considered allocation concealment, blinding of out-
come assessor and intention-to-treat analysis to be po-
tentially important effect modifiers and incorporated
them in our sensitivity analysis. Although we conducted
random-effects analyses regardless of the level of hetero-
geneity, we defined the choice of analysis method (fixed-
effect versus random-effects model) a priori as another
potentially important effect modifier, and therefore
assessed the effect of heterogeneity on estimated treat-
ment comparisons by visually inspecting Bland-Altman
plots [29].
We also conducted a post-hoc meta-regression ana-
lysis of all sham-controlled studies in order to identify
low- and high-inference moderator variables (i.e., cod-
ings) that may have biased outcomes of ADL capacity or
arm function, as measured by UE-FM [35]. For the high-
interference codings, we investigated the impact of the
publication year to investigate novelty effects. For low-
interference codings based on information of the trial it-
self, we investigated factors such as time since stroke,
electric current [mA], duration of stimulation session
[min], number of stimulation sessions, electrode size
[cm2], current density [mA/cm2], electric charge per ses-
sion [C], and charge density per session [C/cm2]. We
used the simultaneous entry approach to fit the meta-
regression model [36].
Results
Study selection
We screened 5709 unique records and assessed 176 full-
text articles for eligibility. We included 30 trials with 868
participants in a qualitative analysis and 26 studies with
754 participants in a quantitative synthesis (meta-ana-
lysis). Figure 1 shows the flow of studies.
Study characteristics
Twenty-four of the 30 studies (80%) were RCTs, and the
remaining six studies (20%) were randomised crossover
trials. The sample sizes of the included studies ranged
from four [37] to 96 [38]. The mean (SD) sample size
was 26 (22) with a median sample size of 20. The mean
age in the experimental groups ranged from 43 to
67 years and that in the control groups from 45 to
75 years. The mean time since stroke ranged from 3 days
to 8 years. The current applied ranged from 1 mA to
2 mA, while the number of stimulation sessions ranged
from five to 30.
A comprehensive summary of the characteristics of
the included trials examining tDCS for improving ADL
capacity and upper limb function, and its safety, can be
found in Additional file 2.
Presentation of network structure
Figure 2 shows a network graph comparing anodal, cath-
odal, and dual tDCS with their control interventions for
improving ADL capacity after stroke. Figure 3 shows a
network graph comparing anodal, cathodal, and dual
tDCS with their control interventions for improving arm
function (measured by the upper extremity UE-FM)
after stroke. Figure 4 shows a network graph comparing
tDCS with their control interventions regarding safety
(measured by the number of dropouts and adverse
events).
Summary of network geometry
A total of 284 patients received active tDCS to improve
their ADL capacity (number of studies = 12, number of
study arms = 27) [38–49]. The intervention types stud-
ied were mostly cathodal tDCS (seven study arms with
167 participants) [38, 43, 44, 46, 49–51], anodal tDCS
(six study arms with 88 participants) [38, 39, 43, 46, 48,
52–56], or dual tDCS (three study arms with 29 partici-
pants) [40, 41, 47]. A total of 163 participants received
sham tDCS as a comparator intervention (number of
studies = 10) [37–41, 44–46]. Two study arms with 45
participants used physical rehabilitation comparators like
virtual reality and physical therapy [44, 45].
A total of 302 patients received active tDCS to im-
prove their arm function, as measured by UE-FM (num-
ber of studies = 16, number of study arms = 35) [38, 39,
43, 44, 46–57]. The intervention types studied were
mostly cathodal tDCS (seven study arms with 140 par-
ticipants) [38, 43, 44, 46, 49–51], anodal tDCS (ten study
arms with 140 participants) [38, 39, 43, 46, 48, 52–56],
or dual tDCS (two study arms with 22 participants) [47,
57]. A total of 214 participants received sham tDCS as a
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Fig. 1 Study flow diagram
anodal
cathodal
dual
physical rehabilitation
sham
Fig. 2 Network graph of tDCS for improving ADL capacity after
stroke. The thicker the edge, the lower the standard error of this
comparison. Colored polygons indicate multi-arm studies
anodal
cathodal
dual
physical rehabilitation
sham
Fig. 3 Network graph of tDCS for improving arm function
(measured by UE-FM) after stroke. The thicker the edge, the lower
the standard error of this comparison. Colored polygons indicate
multi-arm studies. UE-FM: Upper Extremity Fugl-Meyer Assessment
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comparator intervention (number of study arms = 14)
[38, 39, 43, 46–51, 53–57]. Two study arms with 30 par-
ticipants used physical rehabilitation comparators like
virtual reality and physical therapy [44, 52].
We identified 26 trials (number of study arms = 57) with
754 participants which investigated tDCS for improving
ADL capacity or arm function and extracted data regard-
ing the safety of tDCS (number of dropouts and adverse
effects) [37–47, 49–56, 58–62]. The intervention types
studied were mostly anodal tDCS (16 study arms with 174
participants) [37–39, 42, 43, 46, 48, 52–56, 58, 60–62],
cathodal tDCS (11 study arms with 170 participants) [37,
38, 42–46, 49, 51, 58, 59], and dual tDCS (seven study
arms with 65 participants) [40, 41, 47, 57, 58, 61, 63].
Additional file 3 shows the risk of bias within studies of
tDCS for improving ADL capacity, arm function, and safety.
Additional file 4 shows a possible approach to presenting
data from studies examining the effects of tDCS on ADL
capacity and arm function, as well as the safety of the inter-
ventions (anodal, cathodal, dual or sham tDCS, physical re-
habilitation interventions and methylphenidate).
Synthesis of results
Table 1 provides a comparison of effect estimates ob-
tained from the network meta-analysis with effect esti-
mates obtained from direct comparisons by pairwise
meta-analysis of tDCS for improving ADL capacity.
Table 2 shows the ranking of the treatments by P-score,
and Fig. 5 shows the forest plot of tDCS for improving
ADL capacity after stroke.
Table 3 provides a comparison of effect estimates ob-
tained from the network meta-analysis with effect esti-
mates obtained from direct comparisons by pairwise
meta-analysis for improving arm function after stroke.
Table 4 shows the ranking of treatments by P-score,
and Fig. 6 shows the forest plot of tDCS for improving
arm function after stroke.
Table 5 provides a comparison of effect estimates ob-
tained from the network meta-analysis with effect esti-
mates obtained from direct comparisons by pairwise
meta-analysis. Table 6 shows the ranking of treatments
by P-score, and Fig. 7 shows the forest plot of the safety
of tDCS for improving ADL capacity and arm function
after stroke.
Exploration for inconsistency
Significant inconsistency, which means disagreement be-
tween direct and indirect comparisons, was not ob-
served. Visual inspection of the net heat plots of the
three comparisons did not yield excess inconsistency,
and formal testing did not detect statistically significant
design inconsistency (Q = 1.29; df = 2; p = 0.52 for ADL
capacity; Q = 7.3; df = 3; p = 0.06 for arm function, and
Q = 0.88; df = 2; p = 0.66 for safety). The accompanying
net heat plots can be found in Additional file 5.
Risk of bias across studies
We assessed the risk of bias qualitatively for each outcome
by visual inspection of its risk-of-bias graph. We assessed
the risk of bias regarding tDCS for improving ADL cap-
acity and arm function and its safety as low to unclear.
The risk-of-bias graphs can be found in Additional file 3.
anodalcathodal
dual
methylphenidate physical rehabilitation
sham
Fig. 4 Network graph of the safety of tDCS (measured by number of
dropouts and adverse events) after stroke. The thicker the edge, the
lower the standard error of this comparison. Colored polygons
indicate multi-arm studies
Table 1 League table for comparing network estimates with direct estimates of tDCS for improving ADL capacity
Cathodal 0.15 (−0.2; 0.5) – 0.43 (0.0; 0.8) 0.1 (−0.3; 0.4)
0.14 (−0.2; 0.5) Physical rehabilitation – – –
0.19 (−0.4; 0.8) 0.04 (−0.7; 0.8) Dual 0.23 (−0.3; 0.8) –
0.39 (0.1; 0.7) 0.25 (−0.3; 0.8) 0.25 (−0.4; 0.9) Anodal 0.13 (−0.2; 0.5)
0.42 (0.2; 0.7) 0.28 (−0.2; 0.8) 0.23 (−0.8; 0.3) 0.03 (−0.3; 0.3) Sham
League table for comparing network estimates (lower triangle) with direct estimates of pairwise meta-analysis (upper triangle) of tDCS for improving ADL capacity
(SMD and corresponding 95% CI). Treatments are listed in order of relative ranking. Comparisons between treatments should be read from left to right. Their SMD
and corresponding 95% CI can be obtained from the cell shared by the column defining treatment and the row defining treatment. Positive SMDs favor the col-
umn defining treatment for the network estimates (lower triangle) and the row defining treatment for the direct estimates (upper triangle). Physical rehabilitation
means control interventions like physiotherapy, occupational therapy, or virtual reality training
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Results of additional analyses
Our prespecified sensitivity analysis on the effects of
methodological quality regarding our primary outcome
measure (ADL capacity) included four studies with 247
participants with proper allocation concealment, blind-
ing of outcome assessor and intention-to-treat analysis.
Cathodal tDCS remained the most effective stimulation
type (Standardized Mean Difference, SMD = 0.4; 95%
CI: 0.1 to 0.7). The full results of our subgroup analysis
can be found in Additional file 6.
As prespecified in our protocol, we used random-
effects models for each comparison, and additionally
compared them with fixed-effects models in order to as-
sess the effect of heterogeneity on estimated treatment
outcomes. Visual inspection of Bland-Altman plots did
not yield any systematic differences between the results
of fixed- and random-effects models for any of the out-
comes. The results of our sensitivity analyses can be
found in Additional file 6.
We could not identify any statistically significant effect
moderators of tDCS for improving ADL capacity or arm
function. The detailed results of our meta-regression
analyses can be found in Additional file 7.
Discussion
This systematic review with a network meta-analysis in-
cluded 12 randomized controlled trials with 284 partici-
pants examining the effect of tDCS on our primary
outcome, that of ADL capacity. We found evidence of a
significant moderate effect in favor of cathodal tDCS,
whereas no significant effects were found for the other
active tDCS (i.e., dual tDCS, anodal tDCS, and sham
tDCS) or control interventions. Sixteen studies with 302
participants examined our secondary outcome, that of
upper limb motor function as measured with Upper Ex-
tremity Fugl-Meyer Motor scores (UE-FM). We found
no evidence of an effect of cathodal tDCS, dual tDCS,
anodal tDCS, sham tDCS, or physical rehabilitation in-
terventions. Finally, our analysis of 26 trials with 754
participants found no statistically significant differences
between sham tDCS, physical rehabilitation interven-
tions, cathodal tDCS, methylphenidate, dual tDCS, and
anodal tDCS, regarding our other secondary outcome,
that of the safety of tDCS or its control interventions as
revealed by the number of dropouts and adverse events.
The results of this network meta-analysis in terms of
our primary outcome, ADL capacity, are in line with a
recent Cochrane review examining the effects of tDCS
in improving activities, arm and lower extremity func-
tion, muscle strength, and cognition [16]. Due to the
methodological limitations inherent in traditional pair-
wise meta-analyses the authors of that review could only
draw pairwise comparisons, not taking into account the
existing evidence network. Furthermore, in order to
avoid multiple testing, the authors had to combine treat-
ment groups with different types of tDCS into a single
tDCS group, thus maybe masking possible differences
between different tDCS types. In a pre-specified formal
subgroup analysis for their primary outcome of activities,
the authors tried to estimate the treatment effects of the
different tDCS types (anodal, cathodal, and dual tDCS).
The analysis suggested a favorable effect of cathodal
tDCS for improving ADL after stroke (SMD 0.33, 95%
CI 0.10 to 0.57; six studies with 301 participants),
whereas there was no effect for anodal (SMD -0.04, 95%
CI -0.35 to 0.27; five studies with 164 participants) or
dual tDCS (SMD 0.30, 95% CI -0.39 to 0.99; two studies
with 33 participants), which is in accordance with our
findings.
The relative superiority of cathodal tDCS might be
due to a downregulation of the overactive non-affected
brain hemisphere as a result of insufficient interhemi-
spheric inhibition and with that, restoring the balance of
excitatory and inhibitory interactions between both
hemispheres [64–67]. From this point of view, cathodal
tDCS should rather be regarded as supporting the down-
regulation of overactivity of the non-lesioned hemi-
sphere. This might contrast with the model of
‘vicariation of function’ [68, 69] which suggests that un-
affected brain areas ‘take over’ functions of the affected
hemisphere [64, 69]. Recently, doubts have been raised
about whether this model may be oversimplified or even
incorrect and new models have been proposed, such as
Table 2 treatment rankings by P-score of tDCS for improving
ADL capacity
Treatment P-Score
Cathodal 0.87
Physical rehabilitation 0.62
Dual 0.57
Anodal 0.25
Sham 0.18
Treatments are listed in order of relative ranking. The P-Score, ranging from 0
to 1, describes the mean degree of certainty about a particular treatment be-
ing better than another treatment
Intervention
cathodal
physical rehabilitation
dual
anodal
sham
−0.6 −0.2 0 0.2 0.4 0.6
Random Effects Model
Favours sham                          Favours active treatment
SMD
0.42
0.28
0.23
0.03
0.00
95%−CI
[ 0.15; 0.69]
[−0.20; 0.75]
[−0.29; 0.76]
[−0.25; 0.32]
Fig. 5 Forest plot of tDCS for improving ADL capacity after stroke
(12 studies with 284 participants). Treatments are listed in order of
relative ranking. SMD = standardized mean difference,
CI = confidence interval. Sham is the reference category
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the bimodal balance-recovery model, which links inter-
hemispheric balancing to the brain’s remaining struc-
tural reserve [64].
The optimal stimulation paradigm, in terms of the se-
lection of participants likely to benefit from tDCS, the
electrode size and location, the amount of direct current
applied and the duration of administration remains to be
established [14, 64, 70]. Besides the above-mentioned
neurophysiological explanation for the finding of super-
iority of cathodal tDCS, there might also be methodo-
logical reasons. For example, the majority of participants
in randomised studies of tDCS for improving ADL cap-
acity were treated with cathodal tDCS (167 out of 284
participants, 59%). Hence, this intervention might have
the greatest statistical power in showing evidence,
whereas dual tDCS was the least powered intervention.
Regarding our secondary outcome (i.e., function of the
upper paretic limb), our results are in line with two sys-
tematic reviews with pairwise meta-analysis. Tedesco
Triccas and colleagues (2015) included genuine RCTs
with multiple sessions of tDCS for improving the func-
tion of the upper paretic limb after stroke [71]. They in-
cluded nine studies with 371 participants. Their analysis
did not reveal any statistically significant effect of active
tDCS at the end of the intervention period (SMD 0.11,
95% CI -0.17 to 0.38). The other systematic review of
the effects of anodal tDCS on upper extremity function
and cortical excitability in people with stroke also
yielded no evidence of effect (SMD 0.39, 95% CI -0.17 to
0.94) [72]. There have also been systematic reviews with
contradicting results: Butler and colleagues (2013) exam-
ined the effect of anodal tDCS on upper limb motor re-
covery in people with stroke and included randomised
controlled trials, non-randomised trials and pre–post tri-
als. Their analyses revealed a statistically significant
beneficial effect of tDCS on upper limb function (SMD
0.49, 95% CI 0.18 to 0.817; seven studies with 168 partic-
ipants) [73]. One reason for the discrepancy between
their results and ours might be that the authors also in-
cluded non-randomised studies, and that their meta-
analyses suffered from multiplicity.
We found evidence of an effect of tDCS for improving
ADL capacity, but not for improving arm function. Since
there is only a weak association between paresis of one
upper limb after stroke and ADL scores, one could argue
that the improvement in ADL capacity may be not based
on an improvement of the paretic arm itself, but rather
on a generalized treatment effect, or on chance.
A recent systematic review with pairwise meta-
regression explored several stimulation variables, like
electrode size, electric current, current density, tDCS
duration, number of sessions, electric charge, total elec-
tric charge, and total electric charge density [74]. The
authors included ten comparisons of eight RCTs with
213 participants which measured arm function after
stroke. They identified pad size, charge density, and
current density as potentially relevant effect modifiers in
studies measuring arm function by UE-FM, by entering
each of the variables in an inverse variance-weighted
Intervention
cathodal
dual
anodal
sham
physical rehabilitation
−20 −10 0 10 20
Random Effects Model
Favours sham                          Favours active treatment
MD
  2.67
  2.42
  1.74
  0.00
−10.02
95%−CI
[ −1.83;  7.17]
[ −8.62; 13.46]
[ −2.39;  5.88]
[−20.76;  0.72]
Fig. 6 Forest plot of tDCS for improving arm function after stroke
(16 studies with 302 participants). Treatments are listed in order of
relative ranking. MD = mean difference [UE-FM points], CI = confidence
interval. Sham is the reference category
Table 4 Treatment rankings by P-score of tDCS for improving
arm function
Treatment P-Score
Cathodal 0.76
Dual 0.66
Anodal 0.65
Sham 0.41
Physical rehabilitation 0.03
Treatments are listed in order of relative ranking. The P-Score, ranging from 0
to 1, describes the mean degree of certainty about a particular treatment
being better than another treatment
Table 3 League table for comparing network estimates with direct estimates of tDCS for improving arm function
Cathodal – −0.63 (−5.4; 4.2) 4.35 (0.6; 8.1) 3.76 (−7.9; 15.4)
0.25 (−11.7;12.2) Dual – 2.47 (−6.0; 11.0) –
0.93 (−4.0; 5.9) 0.67 (−11.1; 12.5) Anodal 1.45 (−3.5; 6.4) 19.00 (9.4; 28.6)
2.67 (−2.7; 9.0) 2.4 (−8.6; 13.5) 0.67 (−12.5; 11.1) Sham –
13.48 (−1.8; 7.2) 12.44 (−3.0; 27.8) 11.8 (1.38; 22.1) 10.02 (0.72; 20.8) Physical rehabilitation
League table to compare network estimates (lower triangle) with direct estimates of pairwise meta-analysis (upper triangle) of tDCS for improving arm function
(MD and corresponding 95% CI). Treatments are listed in order of relative ranking. Comparisons between treatments should be read from left to right. Their MD
(unit: UE-FM scores) and corresponding 95% CI can be obtained from the cell shared by the column defining treatment and the row defining treatment. Positive
MDs favor the column defining treatment for the network estimates (lower triangle) and the row defining treatment for the direct estimates (upper triangle). Physical
rehabilitation means control interventions like physiotherapy, occupational therapy or virtual reality training. UE-FM: Upper Extremity Fugl-Meyer assessment
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linear meta-regression. We incorporated 19 comparisons
of 16 studies with 302 participants measuring arm func-
tion by UE-FM, and could not find any statistically sig-
nificant potential effect modifier. This might be
explained by our different sample as well as our different
approach to data extraction and meta-regression
analysis.
To our knowledge, our review, including 26 genuine
RCTs with a total of 754 participants, is the most com-
prehensive review so far of the effects and safety of tDCS
regarding ADL capacity and arm function. However, our
study has several limitations. These concern the level of
individual studies and outcomes in the review as well as
that of the review itself. At the level of individual studies,
there is the concern about overestimating treatment ef-
fects and safety due to unclear or sometimes even high
risk of bias, and the fact that the reporting of adverse
events was often unsatisfactory. However, our sensitivity
analysis regarding methodological quality was in accord-
ance with the results of our main analysis. Another as-
pect is that there was methodological and clinical
heterogeneity among the included studies regarding
study type (the majority of included studies were phase
II studies with rather small sample sizes, hence prone to
the risk of baseline imbalance), age of the participants,
time since stroke, dosage of stimulation, electrode loca-
tion, base therapy (i.e., concurrent treatment) and level
of initial severity. This may be due to the fact that the
optimal stimulation paradigm still has to be established,
since theoretical assumptions about the interaction be-
tween motor learning and tDCS-enhanced brain plasti-
city are still weak. This includes the optimal electrode
placement. In popular electrode settings most of the
current is redirected by the skin covering the skull,
hence being unable to ‘trigger’ neurons effectively [14].
Although tDCS easily could be coupled with novel tech-
nologies like, for example robot-assisted training, its
added value to rehabilitation outcomes has been limited
so far [15]. The bimodal balance recovery model might
represent a further step towards a patient-tailored ap-
proach to tDCS. But if an interaction effect is assumed
between motor learning (base therapy) and brain plasti-
city (tDCS), tDCS should start earlier. This, however,
was not supported by our data.
All clinical trials did employ a simplistic dose strategy
of tDCS, assuming increased or decreased excitability of
stimulated brain areas under the anodal and cathodal
electrode, respectively (a detailed qualitative description
of interventions can be found in Additional file 2). How-
ever, recent dose-response studies suggest that anodal or
cathodal tDCS follows a complex, non-linear intensity-
dependent effect on neuronal networks [10, 75]. The
electric fields induced by tDCS applied in current doses
in humans are found not sufficient in themselves to
Table 6 Treatment rankings by P-score of the safety of tDCS
(measured by drop-outs and adverse events during the
intervention phase)
Treatment P-Score
Sham 0.60
Physical rehabilitation 0.57
Cathodal 0.50
Methylphenidate 0.49
Dual 0.46
Anodal 0.38
Treatments are listed in order of relative ranking. The P-Score, ranging from 0
to 1, describes the mean degree of certainty about a particular treatment
being better than another treatment
Intervention
sham
physical rehabilitation
cathodal
methylphenidate
dual
anodal
−0.4 −0.2 0 0.2 0.4
Risk Difference (RD)
Favours active treatment                          Favours sham
RD
0.00
0.00
0.01
0.01
0.01
0.01
95%−CI
[−0.07; 0.07]
[−0.03; 0.04]
[−0.45; 0.47]
[−0.07; 0.09]
[−0.02; 0.05]
Fig. 7 Forest plot of the safety of tDCS for improving ADL capacity
or arm function after stroke (26 studies with 754 participants).
Treatments are listed in order of relative ranking. RD = Risk
Difference, CI = confidence interval. Sham is the reference category
Table 5 League table for comparing network estimates with direct estimates of tDCS for safety of tDCS
Sham – 0.00 (−0.9; 0.1) – 0.01 (−0.1; 0.1) 0.01 (−0.0; 0.1)
0.00 (−0.1; 0.1) Physical rehabilitation 0.01 (−0.1; 0.0) – – 0.00 (−0.2; 0.2)
0.00 (−0.0; 0.0) 0.00 (−0.1; 0.1) Cathodal – 0.00 (−0.7; 0.7) 0.00 (−0.1; 0.1)
0.01 (−0.5; 0.5) 0.01 (−0.5; 0.5) 0.01 (−0.5; 0.5) Methylphenidate 0.00 (−0.5; 0.5)
0.01 (−0.1; 0.1) 0.01 (−0.1; 0.1) 0.01 (−0.1; 0.1) 0.00 (−0.5; 0.5) Dual 0.00 (−0.2; 0.2)
0.01 (−0.1;0.0) 0.01 (−0.1; 0.1) 0.01 (−0.0; 0.0) 0.00 (−0.5; 0.5) 0.00 (−0.1; 0.1) Anodal
League table for comparing network estimates (lower triangle) with direct estimates of pairwise meta-analysis (upper triangle) of the safety of tDCS (measured by
drop-outs and adverse events during intervention phase) (RD and corresponding 95% CI). Treatments are listed in order of relative ranking. Comparisons between
treatments should be read from left to right. Their RD and corresponding 95% CI can be obtained from the cell shared by the column defining treatment and the
row defining treatment. Positive RDs favor the column defining treatment for the network estimates (lower triangle) and the row defining treatment for the direct
estimates (upper triangle). Physical rehabilitation means control interventions like physiotherapy, occupational therapy, or virtual reality training
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trigger spikes but rather to activate neurons at sub-
threshold level [10, 64]. Current animal studies rather
suggest that cathodal and anodal tDCS may respectively,
introduce dendritic hyper- or depolarization of neural
membranes [10, 64]. The tDCS induced polarization of
membranes of the apical dendrite will differ from that of
soma and basal dendrite and dependent on the direction
(i.e., inward (anodal) or outward (cathodal) current [10].
In other words, the localization of hyper-and
depolarization in the cortex will differ in the same
neuron dependent on its cellular composition and its
position in relation with the cortex surface. As a conse-
quence, there is now strong evidence that tDCS may in-
duce long-term potentiation (LTP) and long-term
depression (LTD) of stimulated neuronal pools [10, 64],
which are fundamental for Hebbian and non-Hebbian
forms of neuronal plasticity [76]. Furthermore, anodal
tDCS induced LTP may enhance the secretion of brain
derived nerve growth factors (BDNF) such as GAP43
[77, 78], change interneuronal activity and metabolism
of glia cells [10]. The complexity of neuromodulation by
tDCS suggests that a more sophisticated approach of
tDCS is required to target neural networks effectively in
a functional way [10].
Regarding the review level, there is the concern about
violating the transitivity assumption, which means that in-
cluded studies lack comparability. Violating the assump-
tion of transitivity is more likely in larger treatment
networks or in systematically different study conditions,
like a wide variation in dates of study performance [24].
Neither of these was the case in our analyses. Although
our formal analyses regarding inconsistency in the treat-
ment networks were negative, this does not automatically
mean that no inconsistency occurred [21]. Another point
is that network meta-analyses require reasonably homoge-
neous studies, which is why we restricted our analysis to
the post-intervention effects of tDCS. Since stroke is often
a chronic disease, future network meta-analyses could also
focus on the sustainability of effects of cathodal tDCS, ac-
knowledging that the number of published trials that in-
cluded long-term outcomes is rather small.
Conclusions
Our network meta-analysis of randomised controlled trials
suggests that cathodal tDCS is the most promising treat-
ment option when tDCS is used to improve ADL capacity
and arm function in people with stroke. There is evidence
of an effect of cathodal tDCS in terms of improving ADL
capacity. There is no evidence of an effect of either cathodal
or any other tDCS stimulation type in terms of improving
the function of the upper paretic limb after stroke, as mea-
sured by UE-FM. No difference regarding safety (in terms
of dropouts and adverse events) was seen between different
types of tDCS and their control interventions.
Next to improve the methodological quality of thee
proof-of-concept trials, future trials in humans need to im-
prove reporting the exact dose of tDCS including the elec-
trode montage (electrode size and position) allowing to
replicate findings [9]. In particular, the present meta-
analysis shows that tDCS trials should improve the meth-
odological quality of research. In particular there is room
for improvement with respect to allocation concealment,
report of drop outs and accompanying intention-to-treat
analyses, as well as report of adverse events and long-term
outcomes post intervention.Finally, the current network
meta-analysis also suggests that the scientific rigor of differ-
ent types of tDCS hamper and require a better understand-
ing of its underlying working mechanism [64].
This finding suggests that not only methodological ca-
veats but also technical limitations and insufficient fun-
damental knowledge about the dose-dependent working
mechanism of tDCS may have influenced the current
scientific rigor of this promising therapy.
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